Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income including noncontrolling interests	$ 241,288	$ 290,446
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	79,629	79,556
Impairment and other charges	24,882	0
Share-based compensation expenses related to equity classified awards	19,671	23,862
Non-cash restructuring and other related charges	11,916	0
Amortization of program rights	626,685	610,099
Amortization of deferred carriage fees	15,662	24,747
Unrealized foreign currency transaction loss (gain)	7,778	(1,098)
Amortization of deferred financing costs and discounts on indebtedness	5,876	5,778
Bad debt expense	2,106	2,035
Deferred income taxes	2,973	46,292
Gain on investments	0	(4,084)
Other, net	(4,881)	(7,854)
Changes in assets and liabilities:
Accounts receivable, trade	48,570	99,711
Prepaid expenses and other assets	146,321	(18,174)
Program rights and obligations, net	(844,332)	(1,065,937)
Income taxes payable	16,198	13,181
Deferred revenue	(65,548)	66,822
Deferred carriage fees, net	(4,725)	(22,285)
Accounts payable, accrued liabilities and other liabilities	(198,930)	(106,506)
Net cash provided by operating activities	131,139	36,591
Cash flows from investing activities:
Capital expenditures	(28,392)	(33,510)
Return of capital from investees	696	1,771
Acquisition of investments	(283)	(5,002)
Loans to investees	0	(2,456)
Principal payment received on loan to investee	180	720
Proceeds from sale of investments	8,565	9,854
Net cash used in investing activities	(19,234)	(28,623)
Cash flows from financing activities:
Payments for financing costs	(342)	0
Principal payments on long-term debt	(25,313)	(25,313)
Deemed repurchases of restricted stock units	(7,229)	(21,557)
Principal payments on finance lease obligations	(3,134)	(2,606)
Distributions to noncontrolling interests	(47,546)	(28,232)
Purchase of noncontrolling interests	(1,343)	(2,500)
Net cash used in financing activities	(84,907)	(80,208)
Net increase (decrease) in cash and cash equivalents from operations	26,998	(72,240)
Effect of exchange rate changes on cash and cash equivalents	(1,813)	(29,051)
Cash and cash equivalents at beginning of period	930,002	892,221
Cash and cash equivalents at end of period	$ 955,187	$ 790,930